Drug Name

Rimonabant (also known as SR141716; trade names Acomplia, Bethin, Monaslim, Remonabent, Riobant, Slimona, Rimoslim, Zimulti, and Riomont) is an anorectic antiobesity drug. It is an inverse agonist for the cannabinoid receptor CB1. Its main effect is reduction in appetite. Rimonabant was the first selective CB1 receptor blocker to be approved for use anywhere in the world.
The study also revealed that the screening ability of HbA1c in non-Hispanic Americans differed by race. For example, researchers observed more false- negative results and fewer false-positive results in whites than blacks.

 

Erythromycin is a macrolide antibiotic that has an antimicrobial spectrum similar to or slightly wider than that of penicillin, and is often used for people who have an allergy to penicillins. For respiratory tract infections, it has better coverage of atypical organisms, including mycoplasma and Legionellosis.
Ivermectin is used to treat infections due to certain parasites. Take by mouth, with water, as directed. Depending on your condition and response to therapy, future doses of this medication may be necessary.